Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12519588rdf:typepubmed:Citationlld:pubmed
pubmed-article:12519588lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:12519588lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12519588lifeskim:mentionsumls-concept:C0879626lld:lifeskim
pubmed-article:12519588lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:12519588lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:12519588lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:12519588pubmed:issue4lld:pubmed
pubmed-article:12519588pubmed:dateCreated2003-1-9lld:pubmed
pubmed-article:12519588pubmed:abstractTextGranulopoiesis-stimulating factors (G-CSF and GM-CSF) are being used to prevent febrile neutropenia and infections in the treatment of patients with malignant lymphoma. The question whether G-CSF and GM-CSF improve dose-intensity, tumour response and overall survival in this patient population has not been answered yet. Since the results from single studies are inconclusive a systematic review was required.lld:pubmed
pubmed-article:12519588pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12519588pubmed:languageenglld:pubmed
pubmed-article:12519588pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12519588pubmed:citationSubsetIMlld:pubmed
pubmed-article:12519588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12519588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12519588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12519588pubmed:statusMEDLINElld:pubmed
pubmed-article:12519588pubmed:issn1469-493Xlld:pubmed
pubmed-article:12519588pubmed:authorpubmed-author:ReiserMMlld:pubmed
pubmed-article:12519588pubmed:authorpubmed-author:EngertAAlld:pubmed
pubmed-article:12519588pubmed:authorpubmed-author:SchwarzerGGlld:pubmed
pubmed-article:12519588pubmed:authorpubmed-author:BohliusJJlld:pubmed
pubmed-article:12519588pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12519588pubmed:ownerNLMlld:pubmed
pubmed-article:12519588pubmed:authorsCompleteYlld:pubmed
pubmed-article:12519588pubmed:paginationCD003189lld:pubmed
pubmed-article:12519588pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12519588pubmed:meshHeadingpubmed-meshheading:12519588...lld:pubmed
pubmed-article:12519588pubmed:meshHeadingpubmed-meshheading:12519588...lld:pubmed
pubmed-article:12519588pubmed:meshHeadingpubmed-meshheading:12519588...lld:pubmed
pubmed-article:12519588pubmed:meshHeadingpubmed-meshheading:12519588...lld:pubmed
pubmed-article:12519588pubmed:meshHeadingpubmed-meshheading:12519588...lld:pubmed
pubmed-article:12519588pubmed:meshHeadingpubmed-meshheading:12519588...lld:pubmed
pubmed-article:12519588pubmed:meshHeadingpubmed-meshheading:12519588...lld:pubmed
pubmed-article:12519588pubmed:meshHeadingpubmed-meshheading:12519588...lld:pubmed
pubmed-article:12519588pubmed:year2002lld:pubmed
pubmed-article:12519588pubmed:articleTitleGranulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma.lld:pubmed
pubmed-article:12519588pubmed:affiliationDepartment I of Internal Medicine, University of Cologne, Kerpener Str. 15, Cologne, Germany, 50924. julia.bohlius@medizin.uni-koeln.delld:pubmed
pubmed-article:12519588pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12519588pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12519588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12519588lld:pubmed